"The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections.
Dalvance is intended to treat acute bacterial skin and skin structure infections (ABSSSI) cau"...
Halobetasol Propionate Ointment 0.05% is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Treatment beyond two consecutive weeks is not recommended and the total dosage should not exceed 50 g/week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis Use in children under 12 years of age is not recommended.
DOSAGE AND ADMINISTRATION
Apply a thin layer of Halobetasol Propionate Ointment to the affected skin once or twice daily, as directed by your physician, and rub in gently and completely.
Halobetasol Propionate Ointment is a super-high potency topical corticosteroid; therefore, treatment should be limited to two weeks, and amounts greater than 50 g/wk should not be used. As with other corticosteroids, therapy should be discontinued when control is achieved If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary Halobetasol Propionate Ointment should not be used with occlusive dressings
Halonate™ is supplied in the following:
(NDC 68712-034-01) one 50 g tube of halobetasol propionate ointment 0.05% packaged with one 4 oz can of ammonium lactate mousse 12%
Store between 15°C and 30°C (59°F and 86°F).
Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080. Manufactured for: JSJ Pharmaceuticals, Charleston, SC 29401. 1 -800-499-4468. www.jsjpharm.com. Issued 05/09
Last reviewed on RxList: 8/23/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Halonate Information
Report Problems to the Food and Drug Administration
Find out what women really need.